Argument for Prompt Corneal Cross-Linking on Diagnosis of Keratoconus in a Pediatric Patient

Cornea. 2022 Dec 1;41(12):1471-1472. doi: 10.1097/ICO.0000000000003106. Epub 2022 Aug 24.

Abstract

Strong evidence suggests that corneal crosslinking is a safe procedure capable of stopping or slowing down the progression of keratoconus, avoiding visual loss associated with progression, and delaying or preventing the need for corneal transplantation. The progressive and chronic nature of the disease makes the option for prompt crosslinking upon keratoconus diagnosis in a pediatric patient valid.

MeSH terms

  • Child
  • Collagen / therapeutic use
  • Cross-Linking Reagents / therapeutic use
  • Disease Progression
  • Humans
  • Keratoconus* / diagnosis
  • Keratoconus* / drug therapy
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Riboflavin / therapeutic use
  • Ultraviolet Rays
  • Visual Acuity

Substances

  • Cross-Linking Reagents
  • Collagen
  • Photosensitizing Agents
  • Riboflavin